Japanese Spitz Foundation

    Guide to Japanese Spitz Health and Genetic Mutations

    Yuliya Malinina
    12–18 minutes
    , , ,

    1. Introduction to Japanese Spitz Health

    Japanese Spitz health is often considered strong, with the breed widely regarded as genetically resilient and long-lived. Yet, recent findings from genetic screening programs and case studies reveal that several inherited conditions—earlier undocumented—are found within the breed. These include autosomal recessive diseases, complex traits, and rare or emerging mutations that may influence future breeding decisions.

    The overall health of the Japanese Spitz remains favorable compared to many other companion breeds. Modern DNA testing platforms have expanded our understanding of potential risks. In response, the Japanese Spitz Foundation (JSF) has started a systematic collection of genetic and clinical health data. They are working together with dedicated breeders and national breed clubs. This collaborative effort aims to promote responsible breeding, early detection of inherited conditions, and long-term preservation of Japanese Spitz health.

    2. Confirmed Genetic Mutations in the Japanese Spitz

    2.1 PRA-rcd4 (Progressive Retinal Atrophy – rod-cone dysplasia 4)

    • Gene: C2ORF71 (also referred to as C17H2orf71)
    • Mutation: c.3149_3150insC
    • Inheritance: Autosomal recessive
    • Clinical significance: Causes late-onset retinal degeneration, typically manifesting after 8 years of age.
    • Status in Japanese Spitz: Cases have been confirmed clinically by ECVO-certified ophthalmologists. They have been DNA-tested in both affected and carrier dogs. PRA-rcd4 is now considered the most relevant PRA mutation in the breed.

    2.2 Copper Toxicosis / Wilson Disease

    • Gene: ATP7B
    • Mutation: c.4151G>A
    • Inheritance: Autosomal recessive
    • Clinical significance: Leads to copper accumulation in the liver; linked to liver failure.
    • Status in Japanese Spitz: Mutation found in heterozygous carriers during DNA panel screening. No clinical cases in JS yet reported, but presence warrants monitoring.
    • Clinical signs of Copper Toxicosis are often subtle and may not appear until the dog is middle-aged. Early symptoms can include lethargy, reduced appetite, vomiting, weight loss, and intermittent fever. As the disease progresses, dogs may develop jaundice. They might also experience fluid accumulation in the abdomen (ascites). Bleeding disorders can occur. Additionally, neurological signs like disorientation, head pressing, or seizures may appear due to hepatic encephalopathy. Treatment typically involves chelation therapy with drugs like D-penicillamine or trientine to bind and remove excess copper. Zinc supplementation is used to reduce copper absorption. A low-copper diet and liver-supportive supplements like SAMe or silymarin are also recommended. Early detection through bloodwork, imaging, or genetic screening can help manage the disease before severe liver damage occurs.

    2.3 Cerebellar Ataxia (KCNJ10-related)

    • Gene: KCNJ10
    • Mutation: c.*214_*215insC
    • Inheritance: Autosomal recessive
    • Clinical significance: Progressive loss of coordination and balance; related to spinocerebellar ataxia.
    • Status in Japanese Spitz: Cerebellar Ataxia (KCNJ10-related) has been identified in isolated cases within the breed. Notably, found affected individual not show no overt clinical signs, suggesting the possibility of compensatory mechanisms or variable expressivity. It is recommended to conduct genetic testing for dogs presenting with neurological symptoms. These symptoms include uncoordinated movement, head tremors, or loss of balance. This is particularly important if other causes have been ruled out. Further study is needed to understand the clinical relevance of this mutation in Japanese Spitz.

    2.4 MDR1/ABCB1 Sensitivity (Multidrug resistance mutation)

    • Gene: ABCB1
    • Mutation: c.-6-180T>G
    • Inheritance: Autosomal recessive
    • Clinical significance: Affects blood-brain barrier role, causing sensitivity to certain medications (e.g., ivermectin, loperamide).
    • Status in Japanese Spitz: Detected through full-panel DNA screening; no clinical cases reported but important for drug safety awareness.

    2.5 Factor VII Deficiency

    Factor VII deficiency is a hereditary bleeding disorder. It is caused by a deficiency in coagulation Factor VII. Coagulation Factor VII is a protein essential for proper blood clotting. Affected Japanese Spitz dogs may appear healthy. Yet, the condition can lead to excessive or prolonged bleeding. This occurs after injury or surgical procedures.

    Clinical signs may not be clear until a hemostatic challenge occurs. Such challenges include trauma, spaying/neutering, or dental extractions. Early detection through genetic screening is particularly important in breeding dogs.

    • Gene: F7
    • Mutation: c.407G>A
    • Inheritance: Autosomal recessive
    • Clinical significance: Coagulation disorder that may cause prolonged bleeding times.
    • Factor VII Deficiency Status in Japanese Spitz: The deficiency has been identified in heterozygous form in many Japanese Spitz dogs. This indicates the presence of carriers within the population. DNA-confirmed affected individuals have so far been asymptomatic. Yet, isolated reports within the breed suggest instances of prolonged bleeding. This occurs, for example after surgical procedures. Still, these cases stay not well documented. Further study is needed to assess the true prevalence and clinical significance of this mutation in the breed.

    2.6 IGF1-AS (Insulin-like Growth Factor – short stature)

    Many factors influence an animal’s height. The range of body sizes across different dog breeds suggests a strong genetic aspect. A dog’s height is related not only to its overall size but also to the relative length of its limbs. Genetic analysis has been conducted on dogs from breeds with distinctive typical heights. As a result, several genes impacting this trait have been identified.
    A mutation in the IGF1-AS gene is linked to a reduction in height. This association is particularly noted in breeds where the average standard weight does not exceed 41 kg. In breeds with a standard weight higher than 41 kg, the effect of this mutation is less noticeable. Besides height, this mutation in the IGF1-AS gene is linked to an increase in lifespan.
    The mutation in the IGF1-AS gene is one of the primary genetic causes of reduced dog height. Nonetheless, because this trait is polygenic in inheritance, it only indicates a predisposition. Dogs that are homozygous for this mutation tend to be significantly shorter compared to those without the mutation. Carriers of the mutation typically have intermediate height.

    • Gene: IGF1-AS
    • Mutation: r.1043T>C
    • Inheritance: polygenic
    • Clinical significance: Linked to reduced size or growth delay as well as increase in lifespan
    • Status in Japanese Spitz: In the Japanese Spitz, the IGF1-AS (r.1043T>C) mutation was identified through full-panel genetic screening and appears to correlate with slightly smaller individuals. The mutation forms part of a haplotype believed to influence IGF1 expression. It affects growth hormone sensitivity and affects final height without causing direct health issues. No clinical disorders like dwarfism or metabolic conditions have been linked to this variant in any breed. In summary, the IGF1-AS variant is considered a benign, size-associated polymorphism. In the Japanese Spitz, it may represent natural variation within the breed.

    2.7 Muscular Dystrophy (X-linked)

    Muscular dystrophy is a rare inherited neuromuscular disorder identified in the Japanese Spitz breed. Affected puppies typically begin to show clinical signs between 10 and 12 weeks of age. Early symptoms may include difficulty chewing, excessive salivation, reluctance to exercise, muscle pain, and poor coordination.

    The disease is progressive and incurable, with symptoms gradually worsening over time. Most affected dogs experience a significant decline in mobility. Their quality of life diminishes considerably. Unfortunately, death commonly occurs before one year of age.

    • Genomic location: CFAX: 26,265,569–28,983,547 (CanFam3.1 assembly)
    • Inheritance: X-linked
    • Clinical significance: The X-linked muscular dystrophy linked to the CFAX region (26,265,569–28,983,547, CanFam3.1 assembly). It is a serious inherited condition caused by mutations in the DMD gene, leading to progressive degeneration of skeletal muscle. This disorder is inherited in an X-linked manner. It predominantly affects males. Males typically show with early-onset weakness and rapid progression of clinical signs. Female carriers may stay asymptomatic or show milder symptoms.
    • Status in Japanese Spitz: There was an associated genomic inversion disrupting both the DMD and RPGR genes. While no widespread or extra clinical cases have been confirmed in the breed to date, this case provides important evidence. It shows that X-linked muscular dystrophy can occur in the Japanese Spitz. The affected region has also been flagged by broad genomic screening panels in other dogs. Given the severity of the disease, further monitoring is advised. The disease’s potential presence in the breed is worrying. Monitoring is particularly recommended for males exhibiting early muscular weakness or mobility issues. Carrier detection in women is possible through genetic testing, which may be beneficial for breeding programs aiming to reduce risk.

    3. Other known Japanese Spitz Health Risks

    Patellar Luxation

    Patellar luxation s a common orthopedic condition in small and toy breeds, including the Japanese. It occurs when the kneecap (patella) slips out of its normal position within the femoral groove. This usually happens due to a shallow or malformed groove. The severity can range from mild, intermittent displacement to permanent dislocation. Mild cases may cause only occasional limping or skipping. Severe forms can lead to chronic pain. They can also cause joint damage and need corrective orthopedic surgery.

    Luxation may be medial or lateral and graded from 1 (mild) to 4 (severe). Clinical signs include intermittent lameness, skipping gait, or persistent discomfort. If untreated, moderate to severe cases may lead to pain, arthritis, and impaired mobility. Diagnosis is through physical orthopedic examination, sometimes supported by radiographic imaging. While mild cases may be monitored, advanced cases may need surgical correction. Regular patellar evaluations are recommended in breeding programs to reduce heritable risk and keep breed conformation and soundness.

    Autoimmune Hemolytic Anemia (AIHA)

    AIHA is a serious immune-mediated disease in which a dog’s immune system targets and destroys its own red blood cells. Though not genetically confirmed in the Japanese Spitz, anecdotal evidence in historical clinical records suggests possible cases. These include reports of sudden unexplained anemia, collapse, or non-responsive weakness in adult dogs. No direct genetic cause has been identified in the breed. This supports the need for further investigation. At now, AIHA remains an unconfirmed and rare significant risk.

    Urinary Disorders: Bladder and Kidney Stones

    Urinary conditions are a moderate concern in the Japanese Spitz, encompassing infections, bladder stones (cystoliths), and kidney stones (nephroliths).

    Bladder Stones (Struvite Urolithiasis)

    Struvite stones are commonly linked to urinary tract infections involving urease-producing bacteria (e.g., Staphylococcus, Proteus), which raise urine pH and promote struvite crystal formation. Clinical signs include dysuria, hematuria, urinary accidents, and—in severe cases—vomiting or obstruction-related lethargy. Diagnosis is via urinalysis and imaging. Treatment typically includes a prescription dissolution diet and antibiotics. Though considered an acquired condition, breed-specific susceptibility (e.g., anatomy or immune traits) may play a role. No genetic marker has yet been mapped in the Japanese Spitz.

    Kidney Stones (Nephrolithiasis)

    Nephroliths are less common but more clinically severe, often linked to ureteral obstruction or progressive renal damage. Japanese Spitz cases have been documented via imaging or necropsy, sometimes requiring surgical intervention. Causes are multifactorial (dehydration, metabolic factors, or genetic predisposition), but no specific mutation has been confirmed in the breed. Still, recurring cases within certain lines suggest a possible hereditary part deserving further study.

    Epilepsy in the Japanese Spitz

    Epilepsy is the most common neurological disorder in dogs, caused by abnormal brain activity leading to recurrent seizures. While not common in the Japanese Spitz, confirmed cases exist and may have a hereditary basis.

    Seizures vary in form, affecting consciousness, movement, sensory response, and behavior. They may be generalized with full-body convulsions or focal, limited to one area like a limb. These seizures can escalate over time.

    Diagnosis is made by ruling out other causes via blood tests and neurological exams. There is no cure, but long-term medication can reduce or even remove seizures in some dogs. Dogs with epilepsy should not be bred. Breeders should also avoid crossing lines known to have produced affected offspring, pending the availability of genetic testing.

    Official data is limited. Nevertheless, several confirmed cases have been reported in Finland. A national epilepsy survey is underway to better understand prevalence and inheritance.

    Non-Critical Ophthalmic Conditions

    The Japanese Spitz generally maintains good ocular health. But, ECVO-certified eye screenings over two decades have documented several non-critical or incidental findings:

    Cataracts

    • Cortical cataracts: Mild opacities in the lens cortex, often non-progressive.
    • Posterior polar cataracts: Typically stable and vision-sparing.
    • Anterior suture line cataracts: Considered non-impactful.All documented cases were classified as mild, with no confirmed hereditary pattern.

    Watery Eyes (Overweeping)

    In the Japanese Spitz, a condition commonly referred to as overweeping — or excessively watery eyes — is occasionally observed. Due to the breed’s white coat, tear staining is particularly noticeable, often appearing as reddish-brown marks beneath the eyes. Persistent or excessive tearing is often linked to narrow tear ducts. It may also be related to prominent eyes or dry eye syndrome. Both of which may have a hereditary basis. Yet, mild or temporary tearing can also result from non-hereditary causes, like environmental irritants or teething in young dogs.

    Persistent Pupillary Membranes (PPM)

    PPM refers to embryonic remnants in the eye. there are two versions: Iris-iris – Most common; no visual impairment noted. Iris-cornea – Rare; may pose risk if extensive.

    Other Incidental Ocular Findings

    • Distichiasis/Ectopic cilia: Misplaced eyelashes, occasionally irritating but manageable.
    • Vitreous degeneration/prolapse: Typically harmless.
    • Hypoplastic/micropapilla, papillary coloboma, iris hypoplasia: Congenital anomalies, rarely symptomatic.
    • Corneal dystrophy: Rare, mild, and usually non-progressive.
    • Caruncular trichiasis, entropion: Eyelid abnormalities, manageable surgically if needed.

    Dental disease

    Dental disease is common in small and toy breeds, including the Japanese Spitz. Clinical observations suggest this breed often develops dental calculus early. Owner reports show that gingivitis typically appears by 3 to 5 years of age. No breed-specific mutation has been confirmed, but full-genome panels suggest a possible polygenic influence on plaque buildup and gum inflammation.

    Early and consistent dental care is key. Start brushing from puppyhood. Annual professional cleanings and dental diets or chews are recommended. Left untreated, gingivitis can progress to periodontitis. This can cause tooth loss and jawbone damage. It may even lead to systemic problems like kidney or heart disease. Breeders should track oral health in their lines and include it in long-term choice goals.

    Syndactyly (Fusion of Digits) in the Japanese Spitz

    In the Japanese Spitz, observed cases of syndactyly appear to represent a mild form of soft-tissue digit fusion. This specifically involves the central digital pads rather than full osseous (bone) fusion. This condition is akin to instances in Basenjis and Cavalier King Charles Spaniels. In these breeds, partial fusion of the central paw pads is a non-pathological anatomical variant. Key points:

    • Clinical significance: In the Japanese Spitz, such fusion is not linked to lameness, discomfort, or impaired mobility. Affected dogs lead normal lives and are typically unaware of the anomaly.
    • Comparison with other breeds:
      • In Basenjis, fused central digital pads are well-documented and accepted as a breed trait.
      • In Cavalier King Charles Spaniels, similar fusion is observed sporadically and not considered a disqualifying fault.
    • Status in the Japanese Spitz:
      • To date, there is no evidence of skeletal syndactyly or severe malformations.
      • Documented cases show soft-tissue fusion only, typically between digits II and III.
      • The condition appears congenital and symmetrical, suggesting a hereditary part, but no research of specific mutation has yet been done.

    Mild syndactyly in the Japanese Spitz should be regarded as a cosmetic and non-functional variation. It is comparable to benign variants seen in other breeds. Continued monitoring and documentation may help find its frequency. They may also help detect its inheritance pattern. Yet, at this time, it does not justify exclusion from breeding unless linked with other structural abnormalities.

    4. Implications for Breeding and Research

    Most of these mutations are rare or newly identified within the Japanese Spitz population. Their presence highlights the need for proactive health surveillance. This effort should be supported by national Japanese Spitz clubs. A unified approach integrates DNA profiling, ECVO-certified eye examinations, and systematic clinical data collection. This includes documented causes of death. This method enables breeders and researchers to better trace inheritance patterns. It reduces the risk of carrier-to-carrier matings and prevents the spread of serious hereditary conditions within the breed.

    5. Future Directions

    To guarantee the long-term genetic health of the Japanese Spitz, several key initiatives are underway:

    • Population-wide screening is conducted for known mutations like C2ORF71(PRA-rcd4), ATP7B (copper toxicosis), and KCNJ10 (cerebellar ataxia). This screening assesses their prevalence. It also helps inform risk management strategies.
    • Expanded DNA panel testing for extra mutations of interest, particularly those affecting neurological, hepatic, and skeletal systems.
    • Cross-laboratory collaboration to verify newly detected variants through shared case histories, phenotypic confirmation, and peer-reviewed reporting.
    • Development of a global, health-integrated pedigree database combining DNA test results, clinical diagnoses (e.g., ECVO-certified eye exams), and verified cause-of-death data. This platform aims to empower breeders, veterinarians, and researchers with precise, transparent, and ethically-managed health information.

    The Japanese Spitz Foundation (JSF) is committed to building this collaborative infrastructure. It is actively establishing partnerships with genetic laboratories, breed clubs, and research institutions across Europe and beyond. The foundation welcomes contributions from breeders and scientists worldwide. These contributions support evidence-based breeding decisions. They also encourage responsible preservation of this unique breed.

    We warmly invite breeders, owners, and veterinarians. Join this effort by submitting verified health data. You can also share case histories on our in forms on this website: https://japanesespitz.org. Every report—no matter how small—helps us build a clearer picture of breed health and advance responsible breeding practices.

    References

    Trending